http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#head http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#assertion http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#provenance http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#publicationInfo http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#assertion http://bio2rdf.org/drugbank:DB00398 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00398_DB00958 http://bio2rdf.org/drugbank:DB00958 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00398_DB00958 http://bio2rdf.org/drugbank_resource:DB00398_DB00958 http://purl.org/dc/terms/identifier drugbank_resource:DB00398_DB00958 http://bio2rdf.org/drugbank_resource:DB00398_DB00958 http://purl.org/dc/terms/title DDI between Sorafenib and Carboplatin - Sorafenib may enhance the adverse/toxic effect of carboplatin. Concurrent use of sorafenib with carboplatin and placlitaxel in patients with squamous cell lung cancer is contraindicated. The use of this combination in other settings is not specifically contraindicated, but any such use should be approached with added caution. http://bio2rdf.org/drugbank_resource:DB00398_DB00958 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00398_DB00958 http://www.w3.org/2000/01/rdf-schema#label DDI between Sorafenib and Carboplatin - Sorafenib may enhance the adverse/toxic effect of carboplatin. Concurrent use of sorafenib with carboplatin and placlitaxel in patients with squamous cell lung cancer is contraindicated. The use of this combination in other settings is not specifically contraindicated, but any such use should be approached with added caution. [drugbank_resource:DB00398_DB00958] http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#provenance http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#publicationInfo http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#signature.MCwCFD9g5fJZG39n http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#signature.MCwCFD9g5fJZG39n http://purl.org/nanopub/x/hasSignature MCwCFD9g5fJZG39ntAUpVKnlpGvbVoquAhQGUHjrB9iJk7myfSpBPiJxrf53IA== http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#signature.MCwCFD9g5fJZG39n http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://purl.org/dc/terms/created 2018-03-30T11:13:15.626+02:00 http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E#signature.MCwCFD9g5fJZG39n http://bio2rdf.org/drugbank_resource:DB00398_DB00958_nanopub.RAnhuGEbUOr1OAOiXPR7ksvKZPslcv_R3LuB07Qtwxy_E http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234